Tower Research Capital LLC (Trc) Plus Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.27 - $0.48 $9 - $16	-34 Reduced 0.37%	9,056 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.3 - $8.4 $181 - $5,090	-606 Reduced 6.25%	9,090 $3,000
Q3 2022 Nov 10, 2022	SELL	$0.48 - $7.5 $5,015 - $78,367	-10,449 Reduced 51.87%	9,696 $4,000
Q2 2022 Aug 15, 2022	BUY	$0.46 - $1.02 $4,904 - $10,875	10,662 Added 112.43%	20,145 $11,000
Q1 2022 May 12, 2022	BUY	$0.87 - $1.32 $8,218 - $12,470	9,447 Added 26241.67%	9,483 $9,000
Q4 2021 Feb 14, 2022	BUY	$1.03 - $1.94 $37 - $69	36 New	36 $0
Q2 2021 Aug 16, 2021	SELL	$2.0 - $2.89 $4,124 - $5,959	-2,062 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.1 - $3.75 $3,719 - $6,641	1,771 Added 608.59%	2,062 $5,000
Q4 2020 Feb 16, 2021	SELL	$2.0 - $2.76 $2,012 - $2,776	-1,006 Reduced 77.56%	291 $1,000
Q3 2020 Nov 16, 2020	BUY	$2.11 - $3.17 $2,736 - $4,111	1,297 New	1,297 $3,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $45.7M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.